X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
THSTI has entered into a research collaboration with Nanogen Pharmaceutical, which is developing a new vaccine for COVID-19 named Nano Covax which is the first Covid-19 vaccine to be approved by Vietnam’s Ministry of Health to conduct clinical trial in Vietnam.
Lead Product(s): Nanocovax
Therapeutic Area: Infections and Infectious Diseases Product Name: Nanocovax
Highest Development Status: Phase IIIProduct Type: Vaccine
Recipient: The Translational Health Science and Technology Institute
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration September 27, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
